NCT04625647 2025-12-05Testing the Use of Targeted Treatment (AMG 510) for KRAS G12C Mutated Advanced Non-squamous Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)SWOG Cancer Research NetworkPhase 2 Active not recruiting116 enrolled
NCT04892017 2025-10-10A Phase 1/2 Study of Inlexisertib (DCC-3116) in Patients With RAS/MAPK Pathway Mutant Solid TumorsDeciphera Pharmaceuticals, LLCPhase 1/2 Active not recruiting144 enrolled